The new results could lead to expanded approval of Arikayce and higher salesInsmed said Monday that the addition of its drug Arikayce to a standard treatment for patients with a rare bacterial lung disease improved respiratory symptoms and increased culture conversion rates. The study results achieved the goals of a Phase 3 clinical trial designed […]
